281 related articles for article (PubMed ID: 25424812)
1. Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.
Lin X; Bai G; Lin L; Wu H; Cai J; Ugen KE; Cao C
Hum Vaccin Immunother; 2014; 10(7):2024-31. PubMed ID: 25424812
[TBL] [Abstract][Full Text] [Related]
2. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
3. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
[TBL] [Abstract][Full Text] [Related]
4. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
Zhang Y; Zou J; Yang J; Yao Z
Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
[TBL] [Abstract][Full Text] [Related]
5. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
[TBL] [Abstract][Full Text] [Related]
6. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
7. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
8. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
[TBL] [Abstract][Full Text] [Related]
9. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.
Movsesyan N; Davtyan H; Mkrtichyan M; Petrushina I; Tiraturyan T; Ross T; Agadjanyan MG; Ghochikyan A; Cribbs DH
Hum Gene Ther; 2010 Nov; 21(11):1569-76. PubMed ID: 20528468
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
Chauhan NB; Siegel GJ
Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
[TBL] [Abstract][Full Text] [Related]
13. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain.
Zuo Z; Qi F; Yang J; Wang X; Wu Y; Wen Y; Yuan Q; Zou J; Guo K; Yao ZB
Neurobiol Dis; 2017 May; 101():27-39. PubMed ID: 28189498
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
[TBL] [Abstract][Full Text] [Related]
16. Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.
Cao C; Lin X; Wahi MM; Jackson EA; Potter H
BMC Neurosci; 2008 Feb; 9():25. PubMed ID: 18282292
[TBL] [Abstract][Full Text] [Related]
17. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV
Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896
[TBL] [Abstract][Full Text] [Related]
18. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW
Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T
Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
